Cargando…

Serological Tests Do Not Predict Residual Fibrosis in Hepatitis C Cirrhotics with a Sustained Virological Response to Interferon

BACKGROUND AND AIM: Liver biopsy (LB) has lost popularity to stage liver fibrosis in the era of highly effective anti-hepatitis C virus (HCV) therapy, yet diagnosis of persistent cirrhosis may have important implications following HCV eradication. As performance of serological non-invasive tests (NI...

Descripción completa

Detalles Bibliográficos
Autores principales:	D’Ambrosio, Roberta, Degasperi, Elisabetta, Aghemo, Alessio, Fraquelli, Mirella, Lampertico, Pietro, Rumi, Maria Grazia, Facchetti, Floriana, Grassi, Eleonora, Casazza, Giovanni, Rosenberg, William, Bedossa, Pierre, Colombo, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4909284/ https://www.ncbi.nlm.nih.gov/pubmed/27304619 http://dx.doi.org/10.1371/journal.pone.0155967

Ejemplares similares

Predicting Hepatocellular Carcinoma Risk in Patients with Chronic HCV Infection and a Sustained Virological Response to Direct-Acting Antivirals
por: D’Ambrosio, Roberta, et al.
Publicado: (2021)

Limited Utility of ITPA Deficiency to Predict Early Anemia in HCV Patients with Advanced Fibrosis Receiving Telaprevir
por: Aghemo, Alessio, et al.
Publicado: (2014)

Cirrhosis and Rapid Virological Response to Peginterferon Plus Ribavirin Determine Treatment Outcome in HCV-1 IL28B rs12979860 CC Patients
por: Aghemo, Alessio, et al.
Publicado: (2013)

Deciding on Interferon-Free Treatment for Chronic Hepatitis C: Updating Liver Stiffness Cut-Off Values to Maximize Benefit
por: Colli, Agostino, et al.
Publicado: (2016)

Ribavirin Impairs Salivary gland function During Combination Treatment With Pegylated Interferon Alfa-2a In HEpatitis C patients
por: Aghemo, Alessio, et al.
Publicado: (2011)

The Association of Il28b Genotype with the Histological Features of Chronic Hepatitis C Is HCV Genotype Dependent
por: D’Ambrosio, Roberta, et al.
Publicado: (2014)

Humoral, cellular, clinical responses and safety to SARS-CoV-2 messanger RNA vaccines in patients with compensated and decompensated cirrhosis: a long-term single center prospective study
por: Iavarone, Massimo, et al.
Publicado: (2022)

Reproducibility and diagnostic accuracy of pocket-sized ultrasound devices in ruling out compensated cirrhosis of mixed etiology
por: Costantino, Andrea, et al.
Publicado: (2022)

Treatment of experienced and naïve patients with hepatitis C: focus on telaprevir
por: D’Ambrosio, Roberta, et al.
Publicado: (2012)

Definition of Healthy Ranges for Alanine Aminotransferase Levels: A 2021 Update
por: Valenti, Luca, et al.
Publicado: (2021)

HBV and HCV Therapy
por: Lampertico, Pietro, et al.
Publicado: (2009)

Humoral, cellular, clinical responses and safety of two doses of SARS-CoV-2 Messenger RNA vaccine in patients with compensated and decompensated cirrhosis: a long-term single center prospective study
por: Iavarone, M., et al.
Publicado: (2022)

Sofosbuvir for the treatment of chronic hepatitis C: between current evidence and future perspectives
por: Degasperi, Elisabetta, et al.
Publicado: (2014)

Favorable Outcomes of Chinese HCV-Related Cirrhotic Patients with Sustained Virological Response after Pegylated Interferon Plus Ribavirin Treatment
por: Zhang, Geng-lin, et al.
Publicado: (2017)

Spike-specific humoral and cellular immune responses after COVID-19 mRNA vaccination in patients with cirrhosis: A prospective single center study
por: Iavarone, Massimo, et al.
Publicado: (2023)

The Use of a Pocket-Sized Ultrasound Device Improves Physical Examination: Results of an In- and Outpatient Cohort Study
por: Colli, Agostino, et al.
Publicado: (2015)

Approaches for Selective Vaccinations in Cirrhotic Patients
por: Casella, Giovanni, et al.
Publicado: (2023)

Treatment of Patients With HCV Related Cirrhosis: Many Rewards With Very Few Risks
por: D’Ambrosio, Roberta, et al.
Publicado: (2012)

Performance of Enhanced Liver Fibrosis test and comparison with transient elastography in the identification of liver fibrosis in patients with chronic hepatitis B infection
por: Trembling, P M, et al.
Publicado: (2014)

Towards a Functional Cure for Hepatitis B Virus: A 2022 Update on New Antiviral Strategies
por: Degasperi, Elisabetta, et al.
Publicado: (2022)

Reply to: Correspondence on “High rates of 30-day mortality in patients with cirrhosis and COVID-19”
por: Iavarone, Massimo, et al.
Publicado: (2020)

Hepatitis C Virus Deletion Mutants Are Found in Individuals Chronically Infected with Genotype 1 Hepatitis C Virus in Association with Age, High Viral Load and Liver Inflammatory Activity
por: Cheroni, Cristina, et al.
Publicado: (2015)

Hepatitis D virus infection: Pathophysiology, epidemiology and treatment. Report from the first international delta cure meeting 2022
por: Lampertico, Pietro, et al.
Publicado: (2023)

The Serological and Virological Investigation of Canine Adenovirus Infection on the Dogs
por: Bulut, Oya, et al.
Publicado: (2013)

Virological and serological features of acute hepatitis B in adults
por: Du, Xiaofei, et al.
Publicado: (2017)

Virological and serological findings in dogs with naturally occurring distemper
por: Elia, Gabriella, et al.
Publicado: (2015)

The relationship between liver histology and thyroid function tests in patients with non-alcoholic fatty liver disease (NAFLD)
por: D'Ambrosio, Roberta, et al.
Publicado: (2021)

Longitudinal, virological, and serological assessment of hospitalized COVID-19 patients
por: Signorini, Lucia, et al.
Publicado: (2022)

Role of spleen elastography in patients with chronic liver diseases
por: Giunta, Mariangela, et al.
Publicado: (2016)

Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease
por: Urban, Stephan, et al.
Publicado: (2021)

High rates of 30-day mortality in patients with cirrhosis and COVID-19
por: Iavarone, Massimo, et al.
Publicado: (2020)

Discrepancy between Serological and Virological Analysis of Viral Hepatitis in Hemodialysis Patients
por: Chang, Jer-Ming, et al.
Publicado: (2014)

Epidemiological, Serological, and Virological Features of Dengue in Nha Trang City, Vietnam
por: Quyen, Duong Le, et al.
Publicado: (2018)

Virological surveillance of influenza-like illness in the community using PCR and serology
por: Wallace, Lesley A., et al.
Publicado: (2004)

Virological, Serological and Clinical Analysis of Chikungunya Virus Infection in Thai Patients
por: Tun, Yin May, et al.
Publicado: (2022)

HEPATOCELLULAR CARCINOMA IN A NON-CIRRHOTIC PATIENT WITH SUSTAINED VIROLOGICAL RESPONSE AFTER HEPATITIS C TREATMENT
por: de MATTOS, Angelo Alves, et al.
Publicado: (2015)

Effect of switching from treatment with nucleos(t)ide analogs to pegylated interferon α-2a on virological and serological responses in chronic hepatitis B patients
por: He, Li-Ting, et al.
Publicado: (2016)

Intestinal pseudo-obstruction caused by Giardia lamblia infection
por: Pessarelli, Tommaso, et al.
Publicado: (2022)

Occult HBV infection in HCC and cirrhotic tissue of HBsAg-negative patients: a virological and clinical study
por: Coppola, Nicola, et al.
Publicado: (2016)

VIROLOGICAL AND SEROLOGICAL DIAGNOSIS OF RABIES IN BATS FROM AN URBAN AREA IN THE BRAZILIAN AMAZON
por: de OLIVEIRA, Rubens Souza, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ghdurp1v17lec94a5c1kj0gp57